Molecular Partners Present Data Demonstrating Successful Inhibition of COVID19 Viral Variants with Ensovibep at the 2021 ISIRV-WHO ConferenceGlobeNewsWire • 10/20/21
Molecular Partners Reports Corporate Highlights and Key Financials for H1 2021GlobeNewsWire • 08/26/21
Molecular Partners Reports Continued Progress of Ensovibep Global Clinical Program; Positive in vitro Data Demonstrating Maintained Inhibition of Delta and All Other Known Variants of Concern of SARS-CoV-2GlobeNewsWire • 07/08/21